Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 923,789 shares, an increase of 104.0% from the September 15th total of 452,852 shares. Approximately 1.5% of the company’s shares are short sold. Based on an average daily volume of 287,044 shares, the days-to-cover ratio is currently 3.2 days.
Institutional Trading of Bioceres Crop Solutions
A hedge fund recently raised its position in Bioceres Crop Solutions stock. Ardsley Advisory Partners LP increased its holdings in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) by 691.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 475,000 shares of the company’s stock after buying an additional 415,000 shares during the quarter. Ardsley Advisory Partners LP owned 0.75% of Bioceres Crop Solutions worth $622,000 as of its most recent SEC filing. 17.68% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Friday. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Bioceres Crop Solutions presently has an average rating of “Reduce” and an average price target of $2.00.
Bioceres Crop Solutions Stock Performance
Shares of NASDAQ BIOX opened at $0.33 on Wednesday. The firm has a 50 day moving average price of $0.39 and a 200 day moving average price of $0.42. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.63 and a current ratio of 0.81. Bioceres Crop Solutions has a 52-week low of $0.30 and a 52-week high of $2.19.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its earnings results on Tuesday, September 15th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.33). The firm had revenue of $55.90 million during the quarter, compared to the consensus estimate of $79.00 million. Bioceres Crop Solutions had a negative net margin of 94.76% and a negative return on equity of 39.11%.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. Its offerings include genetically enhanced seeds, biological crop inputs, seed treatments, biostimulants, fertilizers and crop protection products designed for use across major field crops.
The company is best known for its HB4 technology, a drought-tolerance trait developed for wheat and soybeans.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough Road
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
